Bellevue Group AG

SEC CIK: 0001674546
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

AXSM holding history

Axsome Therapeutics, Inc. in every 13F filed by Bellevue Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AXSM overview All 13F holders of AXSM Full Q2 2026 holdings

Shares (Q2 2026): 2,689
Value: $658.2K
% of portfolio: <0.1%
Quarters held: 21; Since Q2 2021

Holdings of AXSM by Bellevue Group AG, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	2,689	$658.2K	<0.1%	−492−15.5%	Reduced	Holders
Q1 2026	3,181	$537.7K	<0.1%	−24,419−88.5%	Reduced	Holders
Q4 2025	27,600	$5.04M	0.1%	−24,735−47.3%	Reduced	Holders
Q3 2025	52,335	$6.36M	0.1%	−3,918−7.0%	Reduced	Holders
Q2 2025	56,253	$5.87M	0.1%	−40,154−41.7%	Reduced	Holders
Q1 2025	96,407	$11.2M	0.3%	−22,523−18.9%	Reduced	Holders
Q4 2024	118,930	$10.1M	0.2%	−248,251−67.6%	Reduced	Holders
Q3 2024	367,181	$33.0M	0.5%	−149,352−28.9%	Reduced	Holders
Q2 2024	516,533	$41.6M	0.7%	−168,943−24.6%	Reduced	Holders
Q1 2024	685,476	$54.7M	0.8%	+50,104+7.9%	Added	Holders
Q4 2023	635,372	$50.6M	0.8%	+3,885+0.6%	Added	Holders
Q3 2023	631,487	$44.1M	0.7%	+57,124+9.9%	Added	Holders
Q2 2023	574,363	$41.3M	0.6%	+133,013+30.1%	Added	Holders
Q1 2023	441,350	$27.2M	0.4%	+4,692+1.1%	Added	Holders
Q4 2022	436,658	$33.7M	0.4%	−59,866−12.1%	Reduced	Holders
Q3 2022	496,524	$22.2M	0.3%	−320,617−39.2%	Reduced	Holders
Q2 2022	817,141	$31.3M	0.4%	+97,659+13.6%	Added	Holders
Q1 2022	719,482	$29.8M	0.3%	+67,545+10.4%	Added	Holders
Q4 2021	651,937	$24.6M	0.3%	−101,008−13.4%	Reduced	Holders
Q3 2021	752,945	$24.8M	0.3%	+400,924+113.9%	Added	Holders
Q2 2021	352,021	$23.7M	0.2%	+352,021	New	Holders